These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3951252)

  • 1. Sensitivity of human hematopoietic cell lines to an alkyl-lysophospholipid-derivative.
    Roos G; Berdel WE
    Leuk Res; 1986; 10(2):195-202. PubMed ID: 3951252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.
    Unger C; Eibl H; Kim DJ; Fleer EA; Kötting J; Bartsch HH; Nagel GA; Pfizenmaier K
    J Natl Cancer Inst; 1987 Feb; 78(2):219-22. PubMed ID: 3468284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of alkyl-lysophospholipid derivatives and low-alkyl-cleavage enzyme activities in rat brain tumor cells.
    Berdel WE; Greiner E; Fink U; Stavrou D; Reichert A; Rastetter J; Hoffman DR; Snyder F
    Cancer Res; 1983 Feb; 43(2):541-5. PubMed ID: 6848177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitoxantrone sensitivity of human hematopoietic cell lines.
    Roos G
    Leuk Res; 1987; 11(6):519-24. PubMed ID: 3600027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells.
    Hoffman DR; Hoffman LH; Snyder F
    Cancer Res; 1986 Nov; 46(11):5803-9. PubMed ID: 3756924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A suppressor lymphokine produced by human T leukemia cell lines. Partial characterization and spectrum of activity against normal and malignant hemopoietic cells.
    Santoli D; Tweardy DJ; Ferrero D; Kreider BL; Rovera G
    J Exp Med; 1986 Jan; 163(1):18-40. PubMed ID: 2416868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonogenicity of normal and malignant hematopoietic progenitor cells after exposure to synthetic alkyl-lymphospholipids.
    Dulisch I; Neumann HA; Löhr GW; Andreesen R
    Blut; 1985 Dec; 51(6):393-9. PubMed ID: 3865693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidylcholine attenuates the cytotoxic effects of the antineoplastic phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3- phosphocholine.
    Boggs KP; Rock CO; Jackowski S
    J Biol Chem; 1995 May; 270(19):11612-8. PubMed ID: 7744800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-induced cell cycle changes in human hematopoietic cell lines and fresh leukemic cells.
    Roos G; Leanderson T; Lundgren E
    Cancer Res; 1984 Jun; 44(6):2358-62. PubMed ID: 6722775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of alkyl-lysophospholipids on phosphatidylcholine biosynthesis in leukemic cell lines.
    Vogler WR; Whigham E; Bennett WD; Olson AC
    Exp Hematol; 1985 Aug; 13(7):629-33. PubMed ID: 3861326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ether lipids on mouse granulocyte-macrophage progenitor cells.
    Vehmeyer K; Kim DJ; Nagel GA; Eibl H; Unger C
    Cancer Chemother Pharmacol; 1989; 24(1):58-60. PubMed ID: 2720891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased membrane permeability for an antitumoral alkyl lysophospholipid in sensitive tumor cells.
    Storch J; Munder PG
    Lipids; 1987 Nov; 22(11):813-9. PubMed ID: 3444371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The differential susceptibility of A427 and A549 cell lines to the growth-inhibitory effects of ET-18-OCH3 does not correlate with the relative effects of the alkyl-lysophospholipid on the incorporation of fatty acids into cellular phospholipids.
    Lu X; Arthur G
    Cancer Res; 1992 May; 52(10):2813-7. PubMed ID: 1581895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cell division but not nuclear division by 1-O- octadecyl-2-O-methyl-Sn-glycero-3-phosphocholine.
    Pushkareva MY; Janoff AS; Mayhew E
    Cell Biol Int; 1999; 23(12):817-28. PubMed ID: 10772756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines.
    Ramilo-Torno LV; Avramis VI
    Cancer Chemother Pharmacol; 1995; 35(3):191-9. PubMed ID: 7805176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiproliferative effect of hexadecylphosphocholine toward HL60 cells is prevented by exogenous lysophosphatidylcholine.
    Boggs K; Rock CO; Jackowski S
    Biochim Biophys Acta; 1998 Jan; 1389(1):1-12. PubMed ID: 9443598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages.
    Herrmann DB; Ferber E; Munder PG
    Biochim Biophys Acta; 1986 Mar; 876(1):28-35. PubMed ID: 3947667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines.
    Civoli F; Daniel LW
    Cancer Chemother Pharmacol; 1998; 42(4):319-26. PubMed ID: 9744778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncytotoxic alkyl-lysophospholipid treatment increases sensitivity of leukemic K562 cells to lysis by natural killer (NK) cells.
    Botzler C; Kolb HJ; Issels RD; Multhoff G
    Int J Cancer; 1996 Mar; 65(5):633-8. PubMed ID: 8598315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alkyl-lysophospholipids on human leukemic cell lines measured by nuclear magnetic resonance.
    Long RC; Small WC; Brynes RK; Tidwell T; Goldstein JH; Vogler WR
    Cancer Res; 1983 Feb; 43(2):770-5. PubMed ID: 6571718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.